BioIVT Expands its Biospecimen Portfolio in Support of Neuroscience Research
Oct 27, 2023
Posted by BioIVT
BIOPROCURE AND PRENDIO ANNOUNCE STRATEGIC GROWTH INVESTMENT FROM PRIMUS CAPITAL
Oct 18, 2023
Posted by Prendio LLC
Genoskin Launches VaxSkin®: A Service Offering to Advance Vaccine Development
Oct 17, 2023
Posted by Genoskin